Resources aid attorneys representing clients harmed by heparin.
There are big problems in the big business of the blood thinner blood thinner
A drug used to prevent the formation of blood clots.
blood thinner Vox populi Anticoagulant, see there heparin, and trial lawyers need to be prepared to handle the fallout. AAJ AAJ All About Jazz (website)
AAJ American Association of Jurists
AAJ American Alpine Journal
AAJ Administrative Appeals Judge
AAJ Attitude Adjust resources can help.
Baxter Healthcare Corp. is the largest U.S. producer of heparin, used daily in hospitals to prevent and treat blot clots in the veins, arteries, and lungs. It is often prescribed before certain surgeries. More than a million multiple-dose vials of heparin are sold each month in the United States, and about half of those are manufactured and distributed by Baxter.
In January, the FDA FDA
Food and Drug Administration
n.pr See Food and Drug Administration.
n.pr the abbreviation for the Food and Drug Administration. learned about an increasing number of potentially life-threatening adverse reactions associated with the use of heparin. Baxter recalled many lots and doses and temporarily stopped manufacturing multiple-dose vials of injectable heparin. Baxter gets the active pharmaceutical ingredients (APIs) for the drug from Scientific Protein Laboratories (SPL (1) (Systems Programming Language) The assembly language for the HP 3000 series. See assembly language for an SPL program example.
(2) (Structured Programming Language) See structured programming.
1. ), which operates a heparin-manufacturing facility in Jiangsu Province, China.
On March 19, FDA scientists identified oversulfated chondroitin sulfate as a contaminant contaminant /con·tam·i·nant/ (kon-tam´in-int) something that causes contamination.
something that causes contamination. in heparin APIs from the Chinese facility. Between January 1, 2007, and May 31, 2008, 246 deaths in patients receiving heparin were reported to the FDA.
Both Baxter and SPL maintain that their pharmaceutical products are safe. Plaintiff attorneys allege that the companies failed to exercise reasonable care in manufacturing, failed to inspect the manufacturing facilities, and failed to recall the defective drug in a timely fashion.
For attorneys taking cases, the AAJ Exchange's new "Tainted Heparin" litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.
When a person begins a civil lawsuit, the person enters into a process called litigation. packet traces the incidents leading to the discovery of contaminated heparin. Materials in the packet include a sample attorney intake form, a sample complaint, pretrial pre·tri·al
A proceeding held before an official trial, especially to clarify points of law and facts.
1. Of or relating to a pretrial.
2. orders from In re Heparin Liability Litigation MDL MDL - (Originally "Muddle"). C. Reeve, Carl Hewitt and Gerald Sussman, Dynamic Modeling Group, MIT ca. 1971. Intended as a successor to Lisp, and a possible base for Planner-70. Basically LISP 1.5 with data types and arrays. 1953, a heparin time line, testimony from the House Energy and Commerce Subcommittee Hearing on Oversight and Investigations, FDA documents, a survey of news articles and medical journals, and more.
In addition, AAJ recently certified a Heparin Litigation Group. Group members have created a document library for sharing materials; the library already contains at least 25 documents and continues to grow. The group plans to add more materials to the document library as they become available.
For more information about this and other litigation packets, log on to the Exchange at www.justice.org/exchange or call (800) 344-3023.
AAJ supports over 85 litigation groups, many of which have active document libraries. For more information, call (202) 965-3500, ext. 700; e-mail email@example.com; or visit www.justice.org/litgroups.